Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biomed Pharmacother ; 80: 87-94, 2016 May.
Article in English | MEDLINE | ID: mdl-27133043

ABSTRACT

Stroke is a major cause of death and disability worldwide. The resulting burden on the society continues to grow, with increase in the incidence of stroke. Oxidative stress has been involved in the pathogenesis of several neurological diseases including acute stroke.Focal and global cerebral ischemia represents diseases that are common in the human population.In recent years much attention is being paid towards the exploration of herbal preparation, antioxidant agents and combination therapies including COX-2 inhibitors in experimental model of stroke.Possible effect of a hydroalcoholic leaf extract of Clerodendron glandulosumColeb (C. glandulosum)on oxidant-antioxidant status in ischemia-hypoperfusion injury in the rat forebrain has been investigated.Healthy adult male Wistar albino rats were divided into five groups (n=8). Group I was served as Sham control (normal saline 1ml/kg, orally), group II was served hypoperfusion control (normal saline 1ml/kg, orally), group III, group IV were served as hydroalcoholic extract treated (200 and 400mg/kg, orally) and group V was treated with Quercetin (10mg/kg, orally) for 14days to assess preventive and curative effects of C. glandulosum. Flavonoid and phenolic compounds exhibit a broad spectrum of biological activity, including antioxidant. C. glandulosum extract (200 and 400mg/kg, p.o) was administered orally, once daily for a period of 2 weeks after the occlusion of BCCA. After 14th days rats were subjected to behavioral studies. After behavioral studies animals were sacrificed and brain was removed and homogenized. Estimation of Lipid peroxidation (LPO) Myeloperoxidase (MPO), estimation of protein levels and the activities of Superoxide dismutase (SOD), Catalase (CAT), were performed. Infarct size and histopathological changes were observed in treated groups.


Subject(s)
Arterial Occlusive Diseases/drug therapy , Carotid Artery, Common/pathology , Clerodendrum/chemistry , Neuroprotective Agents/therapeutic use , Plant Extracts/therapeutic use , Animals , Antioxidants/metabolism , Arterial Occlusive Diseases/pathology , Arterial Occlusive Diseases/physiopathology , Behavior, Animal/drug effects , Brain Infarction/drug therapy , Brain Infarction/enzymology , Brain Infarction/pathology , Carotid Artery, Common/drug effects , Carotid Artery, Common/physiopathology , Cerebrovascular Circulation/drug effects , Male , Maze Learning/drug effects , Neuroprotective Agents/pharmacology , Phytochemicals/analysis , Phytochemicals/pharmacology , Phytochemicals/therapeutic use , Phytotherapy , Plant Extracts/pharmacology , Rats, Wistar , Swimming
2.
Eur Rev Med Pharmacol Sci ; 17(4): 491-500, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23467948

ABSTRACT

BACKGROUND: Reperfusion therapy used in the treatment of cerebral ischemia often causes reperfusion neurological injury. Multiple pathological processes are involved in this injury including oxidative stress and components of the inflammatory response appear to play key roles in these deleterious effects. Thus new therapeutic strategies aimed at neutralization of OS-induced neurotoxicity support the application of natural antioxidant bioflavonoids. Both experimental and epidemiological evidence demonstrate that bioflavonoid such as quercetin and rutin are neuroprotective in models of cerebral ischemia reperfusion injury. However, recent studies indicate that the radical scavenger property of quercetin and rutin is unlikely to be the only reason for their cerebroprotective actions and in fact, a wide spectrum of cellular signaling events may well account for their biological actions. AIM: In this study we attempted to establish the various mechanisms involved in the cerebroprotective activity of quercetin and rutin. METHODS: Adult Sprague Dawely rats were anesthetized with thiopentone and subjected to global cerebral ischemia by occlusion of bicommon carotid arteries. Infarct size (TTC staining), SOD, MDA, CAT and MPO levels was assessed 4 h after the onset of ischemia. RESULTS: Quercetin (50 mg/kg) and rutin (10 mg/kg) administered 10 min before reperfusion resulted in significant reduction of infarct size, MDA, and MPO levels and significant increase in SOD and CAT levels. Administration of L-NAME prior to administration of quercetin and rutin, significantly reduced the cerebroprotection offered by quercetin and rutin. CONCLUSIONS: Possible partial role of antioxidant, anti-inflammatory and involvement of NO in the beneficial effects of bioflavonoids quercetin and rutin against cerebral ischemia reperfusion injury was observed.


Subject(s)
Cerebral Infarction/prevention & control , Neuroprotective Agents/therapeutic use , Quercetin/therapeutic use , Reperfusion Injury/drug therapy , Rutin/therapeutic use , Animals , Antioxidants/metabolism , Cerebral Infarction/etiology , Cerebral Infarction/metabolism , Cerebral Infarction/pathology , Female , Male , NG-Nitroarginine Methyl Ester/pharmacology , Neuroprotective Agents/administration & dosage , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Quercetin/administration & dosage , Rats , Rats, Sprague-Dawley , Reperfusion Injury/complications , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Rutin/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...